What is Ginkgo Bioworks's retained earnings?

Ginkgo Bioworks (DNA) reported retained earnings of -$6.23B in Q1 2026.

How has Ginkgo Bioworks's retained earnings changed year-over-year?

Ginkgo Bioworks's retained earnings decreased by 5.1% year-over-year, from -$5.93B to -$6.23B.

What is the long-term trend for Ginkgo Bioworks's retained earnings?

Over 5 years (2020 to 2025), Ginkgo Bioworks's retained earnings has grown at a 67.4% compound annual growth rate (CAGR), from -$467.88M to -$6.15B.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ginkgo Bioworks DNA Retained Earnings

Retained Earnings at other companies

Thermo Fisher ScientificTMO

$60.63B+11.4%

Charles River LaboratoriesCRL

$1.37B-25.2%

AbCellera Biologics Inc.ABCL

-$72.65M-202%

TEC

Bio-TechneTECH

$1.15B-4.3%

AzentaAZTA

$1.24B—

RegenxbioRGNX

-$1.22B-31.3%

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's retained earnings?: Ginkgo Bioworks (DNA) reported retained earnings of -$6.23B in Q1 2026.
How has Ginkgo Bioworks's retained earnings changed year-over-year?: Ginkgo Bioworks's retained earnings decreased by 5.1% year-over-year, from -$5.93B to -$6.23B.
What is the long-term trend for Ginkgo Bioworks's retained earnings?: Over 5 years (2020 to 2025), Ginkgo Bioworks's retained earnings has grown at a 67.4% compound annual growth rate (CAGR), from -$467.88M to -$6.15B.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.